Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
6
NCT04307082
ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects
Phase: Phase 1
Role: Collaborator
Start: Dec 5, 2019
Completion: Jun 30, 2020